Peripheral neuropathies and anti-glycolipid antibodies
The DOI matches its Crossref record; 296 of the 296 references it cites were found in a registry or an index.
Abstract
This review charts the progress of anti-glycolipid antibodies in neuropathy, from their original discovery 20 years ago in immunoglobulin M paraproteinaemic neuropathy through to current discoveries mapping their relationship to subtypes of Guillain-Barré syndrome. Antibodies to >20 different glycolipids have now been associated with a wide range of clinically identifiable acute and chronic neuropathy syndromes. Particular progress has been achieved in understanding the link between acute motor axonal neuropathy and antibodies to GM1, GD1a, GM1b and GalNAc-GD1a, and between the cranial, bulbar and sensory variants of GBS and antibodies to the disialylated gangliosides GQ1b, GT1a, GD1b and GD3. In addition to clinical and serological studies, the origins and measurement of anti-glycolipid antibodies and their relationships to similar carbohydrate structures on infectious organisms, particularly Campylobacter jejuni, are discussed in the context of a molecular mimicry hypothesis. The structure and nomenclature of relevant glycolipids are outlined, along with information on their localization in nerve, and the influence this has on clinical phenotypes. Major advances have been made in animal modelling of anti-glycolipid antibody-associated diseases, both in vitro and in vivo. This has advanced our understanding of the role of anti-GQ1b antibodies in Miller Fisher syndrome with particular respect to the motor nerve terminal as a potential site of injury, and led to the creation of rabbit models of anti-GD1b and anti-GM1 antibody-mediated sensory and motor neuropathy, respectively. With such information in place, it will now be possible to determine the precise mechanisms by which antibodies injure the different compartments of peripheral nerve and establish how a range of immunomodulating therapies, including current treatments, exert their therapeutic effects. Despite these very significant advances, considerable gaps in our knowledge persist, and it is likely that other pathogenic pathways operate in inflammatory neuropathy that are unrelated to glycolipid antibodies, although these are outside the scope of this review.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the latter instance rare human immune responses against the ganglioside-like structures can even result in serious illness, with the complementfi xing antibodies damaging peripheral nerves (Guillain-Barré syndrome) (990 -991).”
From Biological roles of glycans (2017) · cites this paper as [990]
Citations
Cites
Functional rafts in cell membranes
Simons, K., & Ikonen, E. (1997) · Nature · doi:10.1038/42408 · Cited by 9,757
van der Meché, F. G. A., Schmitz, P. I. M., & the Dutch Guillain–Barré Study Group* (1992) · New England Journal of Medicine · doi:10.1056/nejm199204233261705 · Cited by 1,143
Fisher, M. (1956) · New England Journal of Medicine · doi:10.1056/nejm195607122550201 · Cited by 1,069
Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome
Hadden, R. D. M., Cornblath, D. R., Hughes, R. A. C., Zielasek, J., Hartung, H. ‐., Toyka, K. V., Swan, A. V., & The Plasma Exchange/Sandoglobulin Guillain‐Barré Syndrome Trial Group (1998) · Annals of Neurology · doi:10.1002/ana.410440512 · Cited by 942
The spectrum of antecedent infections in Guillain-Barré syndrome: A case-control study
Jacobs, B. C., Rothbarth, P. H., van der Meché, F. G. A., Herbrink, P., Schmitz, P. I. M., de Klerk, M. A., & van Doorn, P. A. (1998) · Neurology · doi:10.1212/wnl.51.4.1110 · Cited by 826
Defining criteria for autoimmune diseases (Witebsky's postulates revisited)
Rose, N. R., & Bona, C. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90244-f · Cited by 814
Campylobacter jejuni Infection and Guillain–Barré Syndrome
Rees, J. H., Soudain, S. E., Gregson, N. A., & Hughes, R. A. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511233332102 · Cited by 753
THE INFLAMMATORY LESION IN IDIOPATHIC POLYNEURITIS
ASBURY, A. K., ARNASON, B. G., & ADAMS, R. D. (1969) · Medicine · doi:10.1097/00005792-196905000-00001 · Cited by 723
Chiba, A., Kusunoki, S., Obata, H., Machinami, R., & Kanazawa, I. (1993) · Neurology · doi:10.1212/wnl.43.10.1911 · Cited by 705
[10] Gangliosides: Structure, isolation, and analysis
Ledeen, R. W., & Yu, R. K. (1982) · Methods in Enzymology · doi:10.1016/0076-6879(82)83012-7 · Cited by 701
Cited by
Items 701–764 of 764
Metabolomic profiling in inflammatory bowel disease
Hildebrand, D. R. (2017) · ERA
Polyradiculoneuritis in Sarajevo During the War
Vranić, J., & Dautović-Krkić, S. (2006) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2006.3214
Erkrankungen peripherer Nerven
Sturm, D., & Pitarokoili, K. (2018) · Springer eBooks · doi:10.1007/978-3-662-56784-5_6
Characterisation of Campylobacter jejuni Genes Involved in Aerobic Respiration
Calderon-Gomez, L. I. (2012) · Griffith Research Online · doi:10.25904/1912/867
Monoclonal gammopathy associated neuropathy: Focusing on IgM M-protein associated neuropathy
Pruppers, M. H. J., Merkies, I. S. J., & Notermans, N. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814572-2.00005-4
Jones, H. R., Grattan‐Smith, P. J., & Ryan, M. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-417044-5.00020-2
Histological and Clinical Findings in Rabbits Sensitized with GM1 Ganglioside
Untari, N. K. S. D., Kusumastuti, K., Suryokusumo, G., Sudiana, I. K., & Juliandhy, T. (2020) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2020.4871
Abdelmalek, M., & Aissaoui, A. (2016) · Dépôt Institutionnel de lUniversité de Tlemcen
Antecedent infections in neuralgic amyotrophy, a prominent role for hepatitis E virus
van Eijk, J. J. J. (2020) · Radboud Repository (Radboud University)
Chemical and chemoenzymatic synthesis of ganglioside(mimic)s and sulfoglycolipids
Hart, I. M. E. ’. (2021) · Utrecht University Repository (Utrecht University) · doi:10.33540/36
Acute and Chronic Immune Neuropathies and Radiculopathies
Wilks, A. W., & Bucelli, R. C. (2021) · Springer eBooks · doi:10.1007/978-3-030-61883-4_18
(2006) · Elsevier eBooks · doi:10.1016/b978-0-443-07271-0.50022-7
McCluskey, L. F., & Golaszewski, A. L. (2006) · CRC Press eBooks · doi:10.1201/9781420003413.ch10
Karimi, N., Sharifi, A., Zarvani, A., & Cheraghmakani, H. (2015) · Journal of Pediatrics Review · doi:10.17795/jpr-2296
Rabbit Model of Guillain-Barré Syndrome
Yuki, N. (2014) · ASM Press eBooks · doi:10.1128/9781555815554.ch22
Autoantibodies to Glycolipids in Peripheral Neuropathy
Willison, H. J. (2016) · ASM Press eBooks · doi:10.1128/9781555818722.ch100
Self-citationGUILLAIN-BARRÉ SYNDROME, DIAGNOSIS AND MANAGEMENT: SIMPLE LITERATURE REVIEW
Syam, M. M. A. M. A. (2018) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.1973963
Autoantibodies in Neuromuscular Disorders
Querol, L., Gallardo, E., & Illa, I. (2022) · Springer eBooks · doi:10.1007/978-3-031-06731-0_1
Martínez, A., Millán, S. P., Molina, N. C., & Rosselli, D. (2023) · Neurología Argentina · doi:10.1016/j.neuarg.2023.07.004
Pydi, A., Ulavala, P., Palvai, S. C., & Mahesh, V. (2023) · International Journal of Science and Research (IJSR) · doi:10.21275/mr231025081630
Poliradicoloneurite acuta demielinizzante o sindrome di Guillain-Barré
Caldonazzo, J., & Weiss, N. (2023) · EMC - Anestesia-Rianimazione · doi:10.1016/s1283-0771(23)48483-6
Юркин, А. К., Yurkina, E. A., Жигулина, А. И., & Федорец, В. Н. (2023) · Медицина: теория и практика · doi:10.56871/mtp.2023.17.97.008
Neuropatie motorie multifocali con blocco di conduzione
Delmont, É., & Attarian, S. (2024) · EMC - Neurologia · doi:10.1016/s1634-7072(24)48979-4
Vijayan, J., & Lim, S. K. X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99967-0.00264-7
Uchi, T., Konno, S., Kihara, H., & Fujioka, T. (2024) · Research Square · doi:10.21203/rs.3.rs-4677686/v1
Autoantibodies to Glycolipids in Peripheral Neuropathy
Goodfellow, J. A., & Willison, H. J. (2024) · Wiley eBooks · doi:10.1002/9781683674023.ch93
Self-citationGuillain-Barrè Syndrome and Axonal Degeneration
Gallo, C., Vecchio, D., & Comi, C. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_30
Immunopathogenesis of Acute and Chronic Immune-Mediated Disorders of the Peripheral Nervous System
Ruck, T., Öztürk, M., Meuth, S. G., & Hartung, H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95702-1.00438-3
Hu, J., Zheng, Q., Zhou, F., Gao, W., Xu, Y., Liu, Z., & Zhang, M. (2025) · Neurological Research · doi:10.1080/01616412.2025.2509154
Kim, A. Y., Yoo, H. K., Jeon, J. H., & Kwon, H. S. (2025) · Journal of Multiple Sclerosis and Neuroimmunology · doi:10.59578/jmsni.2025.16.1.26-32
Bradley, A., Linhares, M. B., & Lanigan, L. G. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-822528-8.00011-9
Anti‐GD1b Disorder Presenting as Multiple Mononeuropathies
Eid, K., Araoui, R., Ismail, R., & Sawaya, R. A. (2026) · Clinical Case Reports · doi:10.1002/ccr3.72568
Neuropathies périphériques: panorama et actualités
Léger, J. (2008) · Springer eBooks · doi:10.1007/978-2-287-79013-3_7
Gold, R., & Toyka, K. V. (2008) · Springer eBooks · doi:10.1007/978-0-387-72573-4_19
Bader, S. R. (2010) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.12964
Budding, K., Bos, J. W., Dijkxhoorn, K., de Zeeuw, E., Bloemenkamp, L. M., Zekveld, E. M., Groen, E. J. N., Jacobs, B. C., Huizinga, R., Goedee, H. S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25632886
Additional file 1 of Siponimod ameliorates experimental autoimmune neuritis
Uchi, T., Konno, S., Kihara, H., & Fujioka, T. (2023) · Figshare · doi:10.6084/m9.figshare.22602754
Guillain-Barré syndrome: A review
Udomkaewkanjana, A., & Tangsrisuk, G. (2020) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.4038304
Afectación del Sistema Nervioso por el Síndrome Guillain-Barré
Morales Ordóñez, L. (2023) · Deposito de Investigacion Universidad de Sevilla (University of Seville)
Nuevas reactividades antigénicas en neuropatías inmunomediadas
Querol, L., & de Medicina, U. A. D. B. D. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Estudio de biomarcadores con utilidad clínica en neuropatías autoinmunes
Martín-Aguilar, L. (2021) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Motor Nerve Electrophysiology of Guillain-Barré Syndrome.
Drenthen, J. (2022) · EUR Research Repository (Erasmus University Rotterdam)
Clínica e cirurgia de animais de companhia
Patrício, M. A. (2018) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Tetraparesia aguda do neurónio motor inferior em cães
Brás, I. V. D. (2017) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Worstell, N. C. (2018) · OakTrust (Texas A&M University Libraries)
Sindrome di Guillain Barre': attuali terapie farmacologiche in fase clinica
MAGGIO, D. C. (2018) · Electronic Theses and Dissertations Repository (University of Pisa)
Vitor, F. G. R., Chaves, A. V. N., Medeiros, G. D. M. L., de Souza, C. L. P. A., Júnior, J. I. D. S., & de Sousa, M. N. A. (2026) · Revista Ibero-Americana de Humanidades, Ciências e Educação · doi:10.51891/rease.v12i1.23844
AN IN-DEPTH REVIEW OF GUILLAIN-BARRÉ SYNDROME
(2026) · International Journal of Biology Pharmacy and Allied Sciences · doi:10.31032/ijbpas/2026/15.4.10063
Jung, S. (2013) · theses.fr (ABES) · doi:10.70675/5649a9f2zb2fcz45b2zab7czb7c49ceb4a13
Deciphering biosynthesis mechanisms of O-acetylated GD2 in breast cancer
Cavdarli, S. (2020) · theses.fr (ABES) · doi:10.70675/977fb5e0z6886z4fa9z953bzadfb6314f1d2
Johnson, C. E. (2025) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-zry9n6vrn
Huang, J., Li, D., He, R., & Wei, J. (2026) · BMC Neurology · doi:10.1186/s12883-026-05181-0
Revisiting multifocal motor neuropathy: mechanisms, diagnosis and future directions
Dubuisson, N., Rajabally, Y. A., Philips, C., Harbo, T., & Rinaldi, S. (2026) · Brain · doi:10.1093/brain/awag260
Zhou, H., & Guo, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1794662
Hossain, M. M., Rimon, R. H., & Mosarraf, S. B. (2026) · Naogaon Medical College Journal · doi:10.70818/nmcj.v03i01.043
Molecular mimicry revisited: novel perspectives on autoimmune disease initiation and progression
Christen, U., & Hintermann, E. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1922884
Tan, J., Huang, H., Tan, L., & Li, B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1869194
A Review on Guillian Barre Syndrome
Sahu, G., & Sahu, T. (2023) · International Journal of Progressive Research in Science and Engineering
Biology of Demyelinating Diseases
Pham-Dinh, D., & Baumann, N. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7104-3_16
Metadata
- Authors
- Willison, H. J.
- Affiliations
- Southern General Hospital (GB)
- Corresponding author
- Willison, H. J.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-12-01
- Volume
- 125
- Issue
- 12
- Pages
- 2591-2625
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2021949020
- Cited by
- 710
- References
- 286
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 19 · 2023: 22 · 2022: 16 · 2021: 21 · 2020: 19 · 2019: 12 · 2018: 20 · 2017: 23 · 2016: 34 · 2015: 30 · 2014: 37 · 2013: 32 · 2012: 33
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Clinical Neurology › Autoimmune Neurological Disorders and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- anti-glycolipid antibodies, peripheral neuropathy, Guillain-Barré syndrome, Miller Fisher syndrome, acute motor axonal neuropathy, gangliosides, GM1, GD1a, GQ1b, Campylobacter jejuni, molecular mimicry, sensory neuropathy, immunomodulatory therapy
- MeSH terms
- Animals, Autoantibodies, Glycolipids, Humans, Immunoglobulin G, Immunoglobulin M, Peripheral Nervous System Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.